John G. Aunins - Net Worth and Insider Trading
John G. Aunins Net Worth
The estimated net worth of John G. Aunins is at least $56,597 dollars as of 2024-11-13. John G. Aunins is the Chief Technology Officer & EVP of Seres Therapeutics Inc and owns about 85,250 shares of Seres Therapeutics Inc (MCRB) stock worth over $56,597. Details can be seen in John G. Aunins's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John G. Aunins has not made any transactions after 2018-12-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John G. Aunins
John G. Aunins Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John G. Aunins owns 1 companies in total, including Seres Therapeutics Inc (MCRB) .
Click here to see the complete history of John G. Aunins’s form 4 insider trades.
Insider Ownership Summary of John G. Aunins
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2018-12-17 | Chief Technology Officer & EVP |
John G. Aunins Latest Holdings Summary
John G. Aunins currently owns a total of 1 stock. John G. Aunins owns 85,250 shares of Seres Therapeutics Inc (MCRB) as of December 17, 2018, with a value of $56,597.
Latest Holdings of John G. Aunins
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2018-12-17 | 85,250 | 0.66 | 56,597 |
Holding Weightings of John G. Aunins
John G. Aunins Form 4 Trading Tracker
According to the SEC Form 4 filings, John G. Aunins has made a total of 0 transactions in Seres Therapeutics Inc (MCRB) over the past 5 years. The most-recent trade in Seres Therapeutics Inc is the sale of 14,282 shares on December 17, 2018, which brought John G. Aunins around $91,262.
Insider Trading History of John G. Aunins
- 1
John G. Aunins Trading Performance
John G. Aunins Ownership Network
Ownership Network List of John G. Aunins
Ownership Network Relation of John G. Aunins
John G. Aunins Owned Company Details
What does Seres Therapeutics Inc do?
Who are the key executives at Seres Therapeutics Inc?
John G. Aunins is the Chief Technology Officer & EVP of Seres Therapeutics Inc. Other key executives at Seres Therapeutics Inc include Chief Scientific Officer Matthew R. Henn , CFO and EVP Eric D. Shaff , and See Remarks Thomas Desrosier .
Seres Therapeutics Inc (MCRB) Insider Trades Summary
Over the past 18 months, John G. Aunins made no insider transaction in Seres Therapeutics Inc (MCRB). Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 35,175 shares made by Teresa L. Young , a net sale of 33,802 shares made by Eric D. Shaff , and a net sale of 14,878 shares made by Moltke Lisa Von .
In summary, during the past 3 months, insiders sold 31,451 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 31,451 shares. During the past 18 months, 133,982 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,982 shares.
Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seres Therapeutics Inc Insider Transactions
John G. Aunins Mailing Address
Above is the net worth, insider trading, and ownership report for John G. Aunins. You might contact John G. Aunins via mailing address: C/o Seres Health, Inc., 161 First Street, Cambridge Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
